🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In Press: Advances in surgery, imaging, and perioperative care are transforming the management of pancreatic masses, with minimally invasive techniques and personalized strategies improving outcomes ow.ly/8c3y50VWIyY Flavio G Rocha, MD, FACS, FSSO @SKMaithel

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump

Join AHPBA Monday, 06/23, for Pushing the Envelope & the Next Frontier for HCC & Cholangiocarcinoma Register Today: tinyurl.com/374ttdun Adnan Alseidi Shishir K. Maithel

The study on SVC reconstruction during thymic tumor resection demonstrates an 88.2% graft patency rate. Preoperative SVC syndrome and elevated venous pressure were occlusion predictors, while collateral vessel formation may lead to graft failure ow.ly/QY0r50VXJlk

In Press: Surgical Cancer Patients’ Attitudes and Beliefs about #Cannabis at a Midwest Comprehensive Cancer Center ow.ly/6lJh50W0O2Y Flavio G Rocha, MD, FACS, FSSO Michael Cavnar Julie Hallet @SKMaithel Juliet S Lumati (Okoroh) MD MPH FACS FSSO Lee M. Ocuin MD, FACS Aradhya Nigam, MD

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: bit.ly/ea2222-pump cc: Michael Lidsky, MD, FACS

In Press: Laparoscopic Radical Antegrade Modular #Pancreatosplenectomy (RAMPS): Inframesocolic Superior Mesenteric Artery (SMA)-First Approach Beslen Göksoy ow.ly/9roQ50W3J3v Flavio G Rocha, MD, FACS, FSSO Julie Hallet @SKMaithel Juliet S Lumati (Okoroh) MD MPH FACS FSSO Lee M. Ocuin MD, FACS Aradhya Nigam, MD

June Issue: Impact of a technology enhanced breast multidisciplinary #CancerConference ow.ly/qCZu50W4PlL Flavio G Rocha, MD, FACS, FSSO Michael Cavnar Julie Hallet @SKMaithel Juliet S Lumati (Okoroh) MD MPH FACS FSSO Lee M. Ocuin MD, FACS Aradhya Nigam, MD

.Michael Lidsky, MD, FACS of Duke Surgical Oncology and Duke Cancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc: Colorectal Cancer Alliance, Fight Colorectal Cancer, ACS National Colorectal Cancer Roundtable

June Issue: Starting a #HepatoPancreatoBiliary surgery program from scratch: Closing the gap in West Africa Dr Olusegun Alatise Catherine Zivanov ow.ly/EEoQ50W5toE Flavio G Rocha, MD, FACS, FSSO Michael Cavnar Julie Hallet @SKMaithel Juliet S Lumati (Okoroh) MD MPH FACS FSSO Lee M. Ocuin MD, FACS Aradhya Nigam, MD

June Issue: DOTATATE PET CT tumor volume as a predictor of surgical outcome in patients with metastatic #Gastroenteropancreatic #NeuroendocrineTumors Sara Abou Azar, MD ow.ly/CcbY50W6YvV Flavio G Rocha, MD, FACS, FSSO Michael Cavnar Julie Hallet @SKMaithel Lee M. Ocuin MD, FACS Aradhya Nigam, MD

June Issue: Association of neighborhood #SocioeconomicStatus and #EthnicDiversity with receipt of adjuvant chemotherapy in stage III #ColonCancer : A population-based cohort study Adom Bondzi-Simpson, MD, MSc Julie Hallet Andrea Covelli Callisia Clarke MD Natalie Coburn ow.ly/7LAP50W8kfH @SKMaithel

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump

June Issue: Outcomes following #DiagnosticLaparoscopy in patients with #PeritonealCarcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy ( #HIPEC ) due to disease burden Paula Marincola Smith, MD, PhD ow.ly/eTzL50W8YST @SKMaithel

🎯 New in Surgical Oncology Insight: In 🇨🇦’s universal system, Patients with stage III colon cancer from: 🔹 lowest SES areas: 30% ↓ odds 🔹 most diverse areas: 28% ↓ odds of receiving adjuvant chemo. Equity in care ≠ equity in access. 📊👇 Temerty Medicine U of T Public Health Julie Hallet

June Issue: Multidisciplinary management of nonmetastatic locally advanced #ProstateCancer (T3-4N0M0) Marcelo Bigarella, MD ow.ly/xL9Y50Wa4NH Flavio G Rocha, MD, FACS, FSSO Michael Cavnar @SKMaithel Julie Hallet Juliet S Lumati (Okoroh) MD MPH FACS FSSO Lee M. Ocuin MD, FACS Aradhya Nigam, MD

In Press: A retrospective study that identifies two serum biomarkers measured prior to neoadjuvant treatment that are able to discriminate N2 nodal status from N0 and N1 in patients with pancreatic ductal adenocarcinoma. ow.ly/1lXL50WbUT3 Flavio G Rocha, MD, FACS, FSSO @SKMaithel

.Michael Lidsky, MD, FACS of Duke Surgical Oncology and Duke Cancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc: Colorectal Cancer Alliance, Fight Colorectal Cancer, ACS National Colorectal Cancer Roundtable

June Issue: The evolving treatment for early-stage #LungCancer : #Immunotherapy Erin A Gillaspie, MD, MPH, FACS ow.ly/RIRg50Wcl1N Flavio G Rocha, MD, FACS, FSSO Michael Cavnar @SKMaithel Julie Hallet Juliet S Lumati (Okoroh) MD MPH FACS FSSO Lee M. Ocuin MD, FACS Aradhya Nigam, MD

🚨 Don't miss this AHPBA webinar! "Pushing the Envelope and the Next Frontier for HCC & Cholangiocarcinoma" Monday, June 23 | 5:00–6:30pm CT Leading experts explore transplant, immunotherapy & targeted treatments. Register - survey.alchemer.com/s3/8249190/AHP… Sponsored by Genentech